Responses
Regular Abstracts – Part 2
Combination Immunotherapies
897-C TROCEPT tumor-specific targeting and replication enables in-tumor production of immune checkpoint inhibitors following intravenous delivery
Compose a Response to This Article
Other responses
No responses have been published for this article.
